HRCT evaluation has been demonstrated useful in predicting the presence of anti‐MDA5 antibody in DM‐ILD23; however, the prognostic value of HRCT manifestations for MDA5‐DM/CADM‐ILD has not been fully evaluated. Here, IFIH1 is linked to dermatomyositis.